Literature DB >> 10716435

A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.

H Tanaka1, H Arakawa, T Yamaguchi, K Shiraishi, S Fukuda, K Matsui, Y Takei, Y Nakamura.   

Abstract

The p53 gene is frequently inactivated in human cancers. Here we have isolated a p53-inducible gene, p53R2, by using differential display to examine messenger RNAs in a cancer-derived human cell line carrying a highly regulated wild-type p53 expression system. p53R2 contains a p53-binding sequence in intron 1 and encodes a 351-amino-acid peptide with striking similarity to the ribonucleotide reductase small subunit (R2), which is important in DNA synthesis during cell division. Expression of p53R2, but not R2, was induced by ultraviolet and gamma-irradiation and adriamycin treatment in a wild-type p53-dependent manner. Induction of p53R2 in p53-deficient cells caused G2/M arrest and prevented cells from death in response to adriamycin. Inhibition of endogenous p53R2 expression in cells that have an intact p53-dependent DNA damage checkpoint reduced ribonucleotide reductase activity, DNA repair and cell survival after exposure to various genotoxins. Our results indicate that p53R2 encodes a ribonucleotide reductase that is directly involved in the p53 checkpoint for repair of damaged DNA. The discovery of p53R2 clarifies a relationship between a ribonucleotide reductase activity involved in repair of damaged DNA and tumour suppression by p53.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716435     DOI: 10.1038/35003506

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  298 in total

1.  The tumour suppressor protein p53 can repress transcription of cyclin B.

Authors:  K Krause; M Wasner; W Reinhard; U Haugwitz; C L Dohna; J Mössner; K Engeland
Journal:  Nucleic Acids Res       Date:  2000-11-15       Impact factor: 16.971

2.  p53 C-terminal interaction with DNA ends and gaps has opposing effect on specific DNA binding by the core.

Authors:  S B Zotchev; M Protopopova; G Selivanova
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

3.  Identification of ribonucleotide reductase protein R1 as an activator of microtubule nucleation in Xenopus egg mitotic extracts.

Authors:  S Takada; T Shibata; Y Hiraoka; H Masuda
Journal:  Mol Biol Cell       Date:  2000-12       Impact factor: 4.138

Review 4.  Cell cycle checkpoints and their inactivation in human cancer.

Authors:  M Molinari
Journal:  Cell Prolif       Date:  2000-10       Impact factor: 6.831

5.  Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines.

Authors:  S A Maxwell; G E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

6.  Mechanism of exogenous nucleic acids and their precursors improving the repair of intestinal epithelium after gamma-irradiation in mice.

Authors:  Da-Xiang Cui; Guei-Ying Zeng; Feng Wang; Jun-Rong Xu; Dong-Qing Ren; Yan-Hai Guo; Fu-Rong Tian; Xiao-Jun Yan; Yu Hou; Cheng-Zhi Su
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

7.  BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets.

Authors:  Timothy K MacLachlan; Rishu Takimoto; Wafik S El-Deiry
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

8.  Rous-Whipple Award Lecture. Nucleotide excision repair and cancer predisposition: A journey from man to yeast to mice.

Authors:  E C Friedberg
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

9.  Proton Coupled Electron Transfer and Redox Active Tyrosines: Structure and Function of the Tyrosyl Radicals in Ribonucleotide Reductase and Photosystem II.

Authors:  Bridgette A Barry; Jun Chen; James Keough; David Jenson; Adam Offenbacher; Cynthia Pagba
Journal:  J Phys Chem Lett       Date:  2012-02-08       Impact factor: 6.475

10.  Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for Mammalian s phase ribonucleotide reductase.

Authors:  Farnaz Zahedi Avval; Arne Holmgren
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.